-
February 07, 2013
Vivus Inc. (VVUS) recently announced the publication of results from a study regarding its weight-loss drug, Qsymia. ...
-
January 23, 2013
Arena Pharmaceuticals Inc. (ARNA) recently received 'The Day 180 List of Outstanding Issues' from the European ...
-
January 10, 2013
Orexigen Therapeutics, Inc. (OREX) recently provided an update on its obesity candidate, Contrave. The company, ...
-
January 02, 2013
After this morning's trading, the market is looking good. The Nasdaq is trading up 2.3%; the S&P 500 is up 1.8%; and ...
-
January 02, 2013
The market is having a good day so far: the Nasdaq has risen 2.3%; the S&P 500 is up 1.8%; and the Dow has climbed ...
-
December 31, 2012
Takeda Pharmaceutical Company Limited (TKPYY) recently announced that it has mutually terminated its worldwide ...
-
December 27, 2012
It's been a bad day for the market after the morning's trading. The Nasdaq is down 0.7%; the S&P 500 is trading down ...
-
December 17, 2012
On a good day for the market, the Nasdaq has risen 0.5%, the S&P 500 has increased 0.6% and the Dow has moved up ...
-
November 21, 2012
After the morning's trading, the Nasdaq has been relatively flat, the S&P 500 has risen 0.1% and the Dow is trading ...
-
November 09, 2012
Arena Pharmaceuticals Inc.'s (ARNA) loss (excluding special items) of 7 cents per share in the third quarter of 2012 ...
-
November 08, 2012
Vivus Inc. (VVUS) reported a loss of 40 cents per share in the third quarter of 2012, wider than the Zacks Consensus ...
-
November 06, 2012
Weight Watchers continues to struggle to exploit its huge market opportunity.
-
November 06, 2012
The Nasdaq has been relatively flat, the S&P 500 has moved up 0.4% and the Dow has increased 0.6% so far today. Most ...
-
November 06, 2012
The Nasdaq remains relatively unchanged, the S&P 500 has climbed 0.4% and the Dow is trading up 0.6% so far today. ...
-
October 25, 2012
The market is quiet so far today. The Nasdaq has been relatively flat; the S&P 500 is unchanged; and the Dow has ...
-
October 22, 2012
Currently, the Nasdaq is trading up 0.5%, the S&P 500 is unchanged and the Dow has moved little. The healthcare ...
-
October 22, 2012
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently did not ...
-
October 12, 2012
On a bad day for the market, the Nasdaq has declined 0.2%, the S&P 500 has slipped 0.4% and the Dow has fallen 0.2%. ...
-
October 10, 2012
The Nasdaq has been relatively flat, the S&P 500 is down 0.2% and the Dow has decreased 0.5% so far today. The ...
-
October 08, 2012
The Nasdaq has fallen 1%, the S&P 500 has declined 0.4% and the Dow is trading down 0.3%, marking a bad morning for ...